Biotech Completes Dose Escalation Part of Phase 1 Study of COTI-2 in Gynecological Cancers
News
The dose escalation part of a Phase 1 trial evaluating COTI-2 in women with advanced gynecological cancers who did not respond to standard therapy has been completed, according to the ... Read more